Utilization of Opioid Agonist Therapies in Canada

Details

Files
Project Status:
Completed
Project Line:
Health Technology Review
Project Sub Line:
Technology Review
Project Number:
HC0064-000

With Canada’s ongoing opioid crisis, understanding opioid use disorder management strategies, particularly opioid agonist therapy (OAT), is critical. With a range of OATs available and the treatment landscape evolving, it is essential to understand the current utilization patterns of these drugs to quantify their use in Canada and to help inform public drug plan funding decisions and future research on OATs. This utilization analysis examines the utilization of OATs in Canada, including prescribing patterns and expenditures, across public drug plans between 2018 and 2022.